These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 30738957)

  • 1. Immune checkpoints and the regulation of tolerogenicity in dendritic cells: Implications for autoimmunity and immunotherapy.
    Funes SC; Manrique de Lara A; Altamirano-Lagos MJ; Mackern-Oberti JP; Escobar-Vera J; Kalergis AM
    Autoimmun Rev; 2019 Apr; 18(4):359-368. PubMed ID: 30738957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skewing dendritic cell differentiation towards a tolerogenic state for recovery of tolerance in rheumatoid arthritis.
    Schinnerling K; Soto L; García-González P; Catalán D; Aguillón JC
    Autoimmun Rev; 2015 Jun; 14(6):517-27. PubMed ID: 25633325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory dendritic cells in autoimmunity: A comprehensive review.
    Liu J; Cao X
    J Autoimmun; 2015 Sep; 63():1-12. PubMed ID: 26255250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Importance of Dendritic Cells in Maintaining Immune Tolerance.
    Audiger C; Rahman MJ; Yun TJ; Tarbell KV; Lesage S
    J Immunol; 2017 Mar; 198(6):2223-2231. PubMed ID: 28264998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.
    Zhao Y; Zhang A; Du H; Guo S; Ning B; Yang S
    Rheumatol Int; 2012 Apr; 32(4):837-44. PubMed ID: 21904923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity.
    Passeri L; Marta F; Bassi V; Gregori S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases.
    Mackern-Oberti JP; Llanos C; Vega F; Salazar-Onfray F; Riedel CA; Bueno SM; Kalergis AM
    Autoimmun Rev; 2015 Feb; 14(2):127-39. PubMed ID: 25449681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent discoveries in dendritic cell tolerance-inducing pharmacological molecules.
    Švajger U; Rožman PJ
    Int Immunopharmacol; 2020 Apr; 81():106275. PubMed ID: 32044665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits of diversity: heterogenous DC populations allow for both immunity and tolerance.
    Moore JR
    J Theor Biol; 2014 Sep; 357():86-102. PubMed ID: 24816181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Functional Characterization of Murine Tolerogenic Dendritic Cells.
    Wei HJ; Letterio JJ; Pareek TK
    J Vis Exp; 2018 May; (135):. PubMed ID: 29863666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
    Zhou Y; Leng X; Luo S; Su Z; Luo X; Guo H; Mo C; Zou Q; Liu Y; Wang Y
    J Immunol Res; 2016; 2016():5021537. PubMed ID: 28070525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
    Gross CC; Jonuleit H; Wiendl H
    Eur J Immunol; 2012 Mar; 42(3):569-72. PubMed ID: 22488360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?
    Jansen MAA; Spiering R; Broere F; van Laar JM; Isaacs JD; van Eden W; Hilkens CMU
    Immunology; 2018 Jan; 153(1):51-59. PubMed ID: 28804903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients.
    Raϊch-Regué D; Grau-López L; Naranjo-Gómez M; Ramo-Tello C; Pujol-Borrell R; Martínez-Cáceres E; Borràs FE
    Eur J Immunol; 2012 Mar; 42(3):771-82. PubMed ID: 22488365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype.
    Obreque J; Vega F; Torres A; Cuitino L; Mackern-Oberti JP; Viviani P; Kalergis A; Llanos C
    Immunology; 2017 Dec; 152(4):648-659. PubMed ID: 28763099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing tissue specific tolerance in autoimmune disease with tolerogenic dendritic cells.
    Suwandi JS; Toes RE; Nikolic T; Roep BO
    Clin Exp Rheumatol; 2015; 33(4 Suppl 92):S97-103. PubMed ID: 26458178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of anergic and regulatory T cells by plasmacytoid dendritic cells and other dendritic cell subsets.
    Kuwana M
    Hum Immunol; 2002 Dec; 63(12):1156-63. PubMed ID: 12480259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders.
    Chorny A; Gonzalez-Rey E; Fernandez-Martin A; Pozo D; Ganea D; Delgado M
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13562-7. PubMed ID: 16150720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting dendritic cell function during systemic autoimmunity to restore tolerance.
    Mackern-Oberti JP; Vega F; Llanos C; Bueno SM; Kalergis AM
    Int J Mol Sci; 2014 Sep; 15(9):16381-417. PubMed ID: 25229821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases.
    García-González P; Ubilla-Olguín G; Catalán D; Schinnerling K; Aguillón JC
    Autoimmun Rev; 2016 Nov; 15(11):1071-1080. PubMed ID: 27485011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.